Advanced embryo screening technique used during IVF to detect chromosomal abnormalities before embryo transfer.
Preimplantation Genetic Testing (PGT) is a laboratory procedure performed during IVF treatment to analyze embryos for chromosomal abnormalities before implantation. It helps identify genetically healthy embryos, improving the chances of successful pregnancy.
PGT is typically performed at the blastocyst stage after embryo development in a controlled embryology laboratory.
After fertilization—often achieved through ICSI—embryos are cultured to the blastocyst stage. A small biopsy sample is carefully removed and sent for genetic analysis. Healthy embryos are then selected for blastocyst transfer.
This process enhances embryo selection accuracy and may reduce the risk of miscarriage.
PGT is recommended after comprehensive evaluation within the broader fertility diagnosis framework.
Genetic screening procedures are conducted under strict laboratory standards and supervised by experienced fertility specialists including Dr. Nikhil Gosavi, ensuring precision and ethical reproductive care.
No. Genetic testing is recommended in selected cases based on age, history, or medical indication.
While it improves embryo selection, success also depends on uterine health and other biological factors.
When performed by trained embryologists, embryo biopsy is considered safe and controlled.
PGT detects specific chromosomal or known genetic abnormalities but not all possible conditions.
In selected patients, PGT may improve implantation rates and reduce miscarriage risk.

WhatsApp us
Fill out the form below to get instant access.